• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒(SARS-CoV-2)IgM/IgG 抗体检测可在三次核酸检测阴性后确认感染。

SARS-CoV-2 lgM/lgG antibody detection confirms the infection after three negative nucleic acid detection.

机构信息

Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, Fudan University, Shanghai, China.

Department of Infectious Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.

出版信息

J Cell Mol Med. 2020 Jul;24(14):8262-8265. doi: 10.1111/jcmm.15275. Epub 2020 May 19.

DOI:10.1111/jcmm.15275
PMID:32431052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7280606/
Abstract

An ongoing outbreak of viral pneumonia was caused by a novel coronavirus in China in 2019. By March 19, over 200 thousand confirmed cases of SARS-CoV-2 infection and over 9000 deaths have been reported throughout the world. For this infectious disease, nucleic acid detection is still the gold standard for pathogenic detection. However, nucleic acid detection takes a long time and has relatively high "false negative"; therefore, we need urgently a convenient and accurate detection method to make up for this deficiency. In this article, we will show such technical characteristics of lgM/lgG serum antibody detection, compared with nucleic acid detection.

摘要

2019 年中国发生了新型冠状病毒引起的病毒性肺炎疫情。截至 2020 年 3 月 19 日,全球已报告超过 20 万例新型冠状病毒感染确诊病例,死亡人数超过 9000 例。对于这种传染病,核酸检测仍然是病原检测的金标准。然而,核酸检测耗时较长,且具有相对较高的“假阴性”;因此,我们迫切需要一种方便、准确的检测方法来弥补这一不足。本文将展示 lgM/lgG 血清抗体检测与核酸检测相比的技术特点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcf/7348156/db91172ee12f/JCMM-24-8262-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcf/7348156/bbb523a080df/JCMM-24-8262-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcf/7348156/db91172ee12f/JCMM-24-8262-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcf/7348156/bbb523a080df/JCMM-24-8262-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcf/7348156/db91172ee12f/JCMM-24-8262-g002.jpg

相似文献

1
SARS-CoV-2 lgM/lgG antibody detection confirms the infection after three negative nucleic acid detection.新型冠状病毒(SARS-CoV-2)IgM/IgG 抗体检测可在三次核酸检测阴性后确认感染。
J Cell Mol Med. 2020 Jul;24(14):8262-8265. doi: 10.1111/jcmm.15275. Epub 2020 May 19.
2
Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.分析辅助血清学检测在严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染诊断中的应用。
Int Immunopharmacol. 2020 Sep;86:106746. doi: 10.1016/j.intimp.2020.106746. Epub 2020 Jun 26.
3
The Promise and Peril of Antibody Testing for COVID-19.新冠病毒抗体检测的前景与风险
JAMA. 2020 May 19;323(19):1881-1883. doi: 10.1001/jama.2020.6170.
4
Interpreting Diagnostic Tests for SARS-CoV-2.解读新型冠状病毒2019(SARS-CoV-2)诊断检测结果
JAMA. 2020 Jun 9;323(22):2249-2251. doi: 10.1001/jama.2020.8259.
5
A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.一名严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体多次检测不到的新型冠状病毒肺炎(COVID-19)患者。
J Appl Lab Med. 2020 Nov 1;5(6):1401-1405. doi: 10.1093/jalm/jfaa137.
6
Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.新型冠状病毒肺炎患者的抗体检测及动态特征。
Clin Infect Dis. 2020 Nov 5;71(8):1930-1934. doi: 10.1093/cid/ciaa461.
7
Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.新型冠状病毒(SARS-CoV-2)感染的血清学检测在 COVID-19 疫情期间的诊断评估。
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2271-2277. doi: 10.1007/s10096-020-03978-6. Epub 2020 Jul 17.
8
Evaluation of three immunochromatographic tests for rapid detection of antibodies against SARS-CoV-2.三种免疫层析检测方法快速检测 SARS-CoV-2 抗体的评价。
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2289-2297. doi: 10.1007/s10096-020-04010-7. Epub 2020 Aug 17.
9
Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19.美国微生物学会2020年3月23日新型冠状病毒肺炎国际峰会报告:严重急性呼吸综合征冠状病毒2型/新型冠状病毒肺炎诊断检测的价值
mBio. 2020 Mar 26;11(2):e00722-20. doi: 10.1128/mBio.00722-20.
10
The Detection of Novel Coronavirus Antibodies is an Important Supplementary Detection Method for Screening of High-Risk Population.新型冠状病毒抗体检测是筛查高危人群的重要补充检测方法。
Clin Lab. 2020 Jul 1;66(7). doi: 10.7754/Clin.Lab.2020.200504.

引用本文的文献

1
Colorimetric and Raman dual-mode lateral flow immunoassay detection of SARS-CoV-2 N protein antibody based on Ag nanoparticles with ultrathin Au shell assembled onto FeO nanoparticles.基于组装在 FeO 纳米颗粒上的超薄 Au 壳 Ag 纳米颗粒的 SARS-CoV-2 N 蛋白抗体比色和拉曼双通道侧向流动免疫分析检测
Anal Bioanal Chem. 2023 Feb;415(4):545-554. doi: 10.1007/s00216-022-04437-1. Epub 2022 Nov 22.
2
Analysis of trends in patent development for coronavirus detection, prevention, and treatment technologies in key countries.关键国家冠状病毒检测、预防和治疗技术专利发展趋势分析。
J Biosaf Biosecur. 2022 Jun;4(1):23-32. doi: 10.1016/j.jobb.2021.10.005. Epub 2021 Nov 3.
3

本文引用的文献

1
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
2
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
3
Coronavirus Infections-More Than Just the Common Cold.
Evaluation of early antibiotic use in patients with non-severe COVID-19 without bacterial infection.
评价无细菌感染的轻症 COVID-19 患者的早期抗生素使用情况。
Int J Antimicrob Agents. 2022 Jan;59(1):106462. doi: 10.1016/j.ijantimicag.2021.106462. Epub 2021 Oct 23.
4
Research progress in laboratory detection of SARS-CoV-2.SARS-CoV-2 实验室检测的研究进展。
Ir J Med Sci. 2022 Apr;191(2):509-517. doi: 10.1007/s11845-021-02604-4. Epub 2021 Mar 24.
5
Risk factors and prevention strategies for the occupational exposure of medical staff during the coronavirus disease-19 pandemic (Review).2019冠状病毒病大流行期间医务人员职业暴露的危险因素及预防策略(综述)
Exp Ther Med. 2021 Feb;21(2):176. doi: 10.3892/etm.2020.9607. Epub 2020 Dec 28.
6
Summary of the Detection Kits for SARS-CoV-2 Approved by the National Medical Products Administration of China and Their Application for Diagnosis of COVID-19.中国国家药品监督管理局批准的 SARS-CoV-2 检测试剂盒摘要及其在 COVID-19 诊断中的应用。
Virol Sin. 2020 Dec;35(6):699-712. doi: 10.1007/s12250-020-00331-1. Epub 2020 Dec 22.
7
Updates on laboratory investigations in coronavirus disease 2019 (COVID-19).2019年冠状病毒病(COVID-19)实验室检查的最新进展。
Acta Biomed. 2020 Sep 7;91(3):e2020030. doi: 10.23750/abm.v91i3.10187.
8
A new and rapid approach for detecting COVID-19 based on S1 protein fragments.一种基于S1蛋白片段检测新型冠状病毒肺炎的全新快速方法。
Clin Transl Med. 2020 Jun;10(2):e90. doi: 10.1002/ctm2.90. Epub 2020 Jun 5.
9
Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.COVID-19/SARS-CoV-2 在头五个月的科学研究进展。
J Cell Mol Med. 2020 Jun;24(12):6558-6570. doi: 10.1111/jcmm.15364. Epub 2020 May 7.
冠状病毒感染——远不止是普通感冒。
JAMA. 2020 Feb 25;323(8):707-708. doi: 10.1001/jama.2020.0757.